Cross-sectional biomarker comparisons in asthma monitoring using a longitudinal design: The eNose premise

Allergy. 2020 Oct;75(10):2690-2693. doi: 10.1111/all.14354. Epub 2020 Jun 16.

Mahmoud I Abdel-Aziz^{1

2}, Rianne de Vries^{1

3}, Ariana Lammers¹, Binbin Xu⁴, Anne H Neerincx¹, Susanne J H Vijverberg¹, Yennece W F Dagelet¹, Aletta D Kraneveld^{5

6}, Urs Frey⁷, René Lutter^{1

8}, Peter J Sterk¹, Anke H Maitland-van der Zee^{1

9}, Anirban Sinha^{1

7

8}

¹ Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
² Department of Clinical Pharmacy, Faculty of Pharmacy, Assiut University, Assiut, Egypt.
³ Breathomix BV, Reeuwijk, The Netherlands.
⁴ EuroMov Digital Health in Motion, Univ Montpellier, IMT Mines Ales, Ales, France.
⁵ Division of Pharmacology, Faculty of Science, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands.
⁶ Faculty of Veterinary Medicine, Institute for Risk As-+essment Sciences, Utrecht University, Utrecht, the Netherlands.
⁷ Department of Biomedical Engineering and University Children's Hospital, University of Basel, Basel, Switzerland.
⁸ Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
⁹ Department of Paediatric Respiratory Medicine, Amsterdam UMC, Emma Children's Hospital, Amsterdam, The Netherlands.

No abstract available

Keywords: VOCs; asthma; biomarker; cross-sectional; eNose; longitudinal; rhinovirus.

Publication types